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ABSTRACT 
Objective: A simple, direct and accurate spectrophotometric method has been developed for the determination of glimepiride (GLM) in pure and 
pharmaceutical formulations by complex formation with bromocresol green (BCG).  
Methods: The method involves the formation of a yellow ion-pair complex between bromocresol green reagent with glimepiride (C24H34N4O5S); 
after reacted it with Na2CO3 to give C24H33N4H+O5NaS in chloroform at pH≤3.8.  
Results: The formed complex was measured at λmax 416 nm against the reagent blank prepared in the same manner. Variables were studied in 
order to optimize the reaction conditions. Beer’s law was obeyed in the concentration range of 0.981-9.812 μg/ml in the present of 1x10-4 mol/l of 
(BCG) and 9.812-58.874 μg/ml in the present of 1x10-3 mol/l of (BCG) with good correlation coefficient (R2= 0.9992 and R2= 0.9997, respectively). 
The relative standard deviation did not exceed 3.0%. The limit of detection (LOD) and the limit of quantification (LOQ) were 0.088 and 0.29 μg/ml, 
respectively. The proposed method was validated for specificity, linearity, precision and accuracy, repeatability, sensitivity (LOD and LOQ), and 
robustness with average recovers 98.9 to 102.4%. 
Conclusion: The developed method is applicable for the determination of glimepiride in pure and different dosage forms with average assay of 
marketed formulations 97.8 to 102.4% and the results are in good agreement with those obtained by the RP-HPLC reference method.  
Keywords: Direct spectrophotometric method, Glimepiride, Bromocresol green, Ion-pair complex  
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INTRODUCTION 
Glimepiride (GLM) belongs to sulfonylurea oral anti-diabetic. GLM is 
a white to yellowish-white, odorless, crystalline powder insoluble in 
water. It is chemically described as 1-[[p-[2-(3-ethyl-4methyl-2-oxo-
3-pyrroline-1carboxamido) ethyl] phenyl] sulfonyl]-3-(trans-4-
methylcyclohexyl) urea (C24H34N4O5S) with a mol. mass of 490.62 g 
[1, 2], see Scheme 1.  
 
 
Scheme 1: Chemical structure of glimepiride 
 
Bromocresol green (C21H14Br4O5S), mol. mass 698.01 g, is a dye of 
the triphenylmethane family (triaryl methane dyes) [3], see scheme 
2. Bromocresol green has been used as a reagent to form ion pair 
complexes with drugs [4, 5]. 
Various spectrophotometric methods [6-20] have been reported for 
the determination of glimepiride in pure as well as in dosage forms. 
Most spectrophotometric methods employ ion-pair extraction 
procedures. In this case, the ion-pair complex was extracted into an 
organic solvent, which is immiscible with water, and the 
concentration of the resulting ion-pair in the organic phase is 
determined spectrophotometrically. The ion-pair extraction 
technique has some difficulties and inaccuracies due to incomplete 
extraction or the formation of emulsions between the hydrocarbon 
solvent and the basic compound-containing solution. 
 
Scheme 2: Chemical structure of bromocresol green 
(C21H14Br4O5S) 
 
In response to the problems resulting from the extraction of the ion-
pair complex, it is better to determine formed ion pair complex 
without extraction [17]. Also, none of the methods reported in the 
literature is based on the formation of a complex between 
bromocresol green and GLM. 
In this study, an extraction-free spectrophotometric method for 
determination of GLM through ion-pair complex formation with 
bromocresol green was developed. 
MATERIALS AND METHODS 
Instruments and apparatus 
Spectrophotometric measurements were made in Spectro scan 80 
DV UV-VIS spectrophotometer with 1 cm quartz cells. An ultrasonic 
processor model Power sonic 405 was used to sonicate the sample 
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solutions. The diluted pipette model DIP-1 (Shimadzu), having 100 
μl sample syringe and five continuously adjustable pipettes covering 
a volume range from 20 to 5000 μl (model Piptman P, GILSON). 
Centrifuge (Centurion Scientific Ltd., Model: K2080-Manufactured in 
the United Kingdom) was used for the preparation of the 
experimental solutions. SARTORIUS TE64 electronic balance was 
used for weighing the samples. 
Reagents 
Glimepiride (99.98%) was supplied by Chempi fine chemicals 
(INDIA). Bromocresol green (97%) of analytical grade, chloroform 
and Na2CO3 extra pure were from MERCK. All solvents and reagents 
were analytical grade chemicals. 
Stock standard solution of bromocresol green (1x10-2 mol/l) 
Accurately weighed 179.9 mg of BCG was dissolved in chloroform into 
a volumetric flask (25 ml) and diluted up to mark with chloroform. 
Stock standard solution of GLM (1x10-3 mol/l) 
This solution was prepared by good mixing 12.27 mg of GLM with 
0.05 g of Na2CO3, adding 0.1 ml H2O, drying well in 105 oC, after that 
dissolving in chloroform, filtering over a 25 ml flask and washing by 
the same solvent, then diluting to 25 ml with chloroform.  
Working standard solutions of glimepiride 
The stock solution was further diluted daily just before the use to 
obtain working solutions of GLM in the concentrations: 2, 4, 6, 8, 10, 
15, 20, 30, 40, 50, 60, 80, 100 and 120 μM (0.981, 1.962, 2.944, 
3.925, 4.906, 7.359, 9.812, 14.718, 19.625, 24.530, 29.437, 39.249, 
49.062 and 58.874 μg/ml) by transferring different aliquots from 
stock standard solution: 20, 40, 60, 80, 100, 150, 200, 300, 400, 500, 
600, 800, 1000 and 1200 μl into 10 ml volumetric flasks, then 1 ml 
from stock standard solution of BCG was added, diluted to 10 ml 
with chloroform.  
Sample preparation  
Commercial formulations (as a tablet) were used for the analysis of 
glimepiride. The pharmaceutical formulations subjected to the 
analytical procedure were:  
(1) Glimaryl tablets, Asia pharma Co., Aleppo–SYRIA (Mfg. 02/2015, 
Exp. 02/2018), each tablet contains: 2 and 4 mg of GLM )2(  Amarium 
tablets, Racha lab., Aleppo–SYRIA (Mfg. 01/2014, Exp. 02/2017), 
each tablet contains: 2 and 4 mg of GLM. 
Stock solutions of pharmaceutical formulations 
20 tablets of each studied pharmaceutical formulation were weighed 
accurately, crushed to a fine powder and mixed well. An amount of the 
powder equivalent to the weight of one tablet was mixed well with 0.05 
g of Na2CO3 and solved in chloroform using ultrasonic, 10 ml of 
chloroform was added, filtered over a 10 ml flask and washed by the 
same solvent, then diluted to 10 ml with chloroform. This solution 
contains the follows: 200 and 400 µg/ml of GLM for all studied 
pharmaceutical formulations contain 2 and 4 mg/tab, respectively. 
Working solutions of pharmaceutical 
Five solutions were prepared daily by diluting 1.000 ml from each 
stock solution of pharmaceutical formulations for contents: 2 and 4 
mg/tab, then adding 1 ml from stock standard solution of BCG and 
adjusting the volume up to 10 ml with chloroform (these solutions 
contain 20 or 40 μg/ml of GLM respectively; test solutions). 
Procedure 
A solution (10 ml) containing an appropriate concentration of GLM 
(or working solutions of pharmaceuticals) with appropriate amount 
of bromocresol green in chloroform was ready for spectro-
photometric measurement at λmax 416 nm.  
RESULTS AND DISCUSSION 
The different experimental parameters affecting the spectro-
photometric determination of glimepiride through ion-pair complex 
formation with bromocreol green in chloroform were studied in order 
to determine the optimal conditions for the determination of GLM.  
Spectrophotometric results  
UV-Vis spectra of GLM, BCG and the formed complex GLM: BCG 
solutions (using chloroform as blank or 1x10-3M of BCG in 
chloroform) were obtained. GLM solutions do not absorb in the 
range 300-600 nm. Bromocresol green (BCG) solutions have small 
absorption at λmax 416 nm (ε=430  l. mol-1. cm-1). BCG: GLM complex 
solutions have maximum absorption at λmax 416 nm, (ε=12000  l. mol-
1. cm-1), see fig. 1.  
The effect of time and temperature 
The effect of time and temperature on the complex formation was 
studied within the ranges 5-120 min and 15-30 oC. It was found that the 
formed complex wasn't affected by time or temperature at those ranges.  
The effect of BCG concentration  
The effect of BCG concentration on complex formation was 
investigated. It was observed that the absorbance of the formed 
complex increased coinciding with increasing the ratio of CBCG: CGLM 
until the ratio (1:1), then stayed quasi-constant. 
 
 
Fig. 1: UV-Vis spectra in chloroform of:  
1-1.0x10-4 mol/l of GLM; 2-1x10-4 mol/lof BCG; 3,4-1.0x10-4 
mol/l ion-pair complex (1.0x10-4 mol/l of GLM with 1.0x10-3 
mol/l of BCG); 1-3 blank is chloroform and 4-blank is 1x10-3M of 
BCG in chloroform, ℓ =1 cm 
 
Composition of GLM: BCG complex 
The composition of GLM: BCG complex was determined by the molar 
ratio method and Job's method of continuous variation. 
Molar ratio method  
The stoichiometry of GLM: BCG complex was studied by molar ratio 
method according to the following equation: Amax= f([GLM]/[BCG]). 
It confirmed that the binding ratio of GLM: BCG complex is equal to 
(1:1); where the concentration of BCG was constant 50 µM and the 
concentrations of GLM changed from 0 to 100 µM 
(fig. 2). The formation constant of the ion pair complex is 1.12x107. 
Job’s method of continuous variation 
Continuous variation was utilized to check the composition of GLM: 
BCG complex. The absorbance of the complex was plotted against 
the mole fraction [GLM]/[GLM]+[BCG]. The plot reached a maximum 
value at a mole fraction of 0.5 (fig. 3). This indicated complex 
formation (GLM: BCG) in the ratio of 1:1. The formation constant of 
the ion pair complex is 1.03x107. 
The optimum conditions for spectrophotometric determination of 
glimepiride through ion-pair complex formation using bromocresol 
green in chloroform are shown in table 1. 
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Fig. 2: Molar ratio method to calculate binding ratio of GLM: BCG 
complex at λ=416 nm ([BCG]= 50 µM, blank is chloroform, ℓ =1 cm) 
 
 
Fig. 3: Job's method of continuous variation to calculate binding 
ratio of GLM: BCG complex at λ 416 nm ([BCG]+[GLM]=100 µM, 
blank is chloroform, ℓ =1 cm) 
 
Table 1: The optimum conditions for spectrophotometric 
determination of GLM by complex formation with BCG in 
chloroform 
Parameters Operating modes 
Temperature of solution 20±5oC 
CBCG: CGLM, M ≥5 
Solvent chloroform 
Stability  24 h 
λmax of GLM: BCG complex 416 nm 
Light path (ℓ) 1.0 cm 
Spectra range 300–600 nm 
Mechanism of reaction 
Anionic dyes such as BCG form ion-pair complexes with the 
positively charged nitrogen-containing molecule. The colour of 
such dyes is due to the opening of lactoid ring and subsequent 
formation of quinoid group (deprotonated). Glimepiride 
(C24H34N4O5S) is reacted with Na2CO3 to give (C24H33N4H+O5NaS), 
then dissolved in chloroform and forms yellow ion-pair complex 
with the dye (at pH≤ 3.8; in pH>5.4 and alkaline solution BCG 
gives blue colour).  
Each drug-dye complex with two oppositely charged ions 
(positive on the drug and negative on the dye) behaves as a 
single unit held together by an electrostatic binding [8, 21-24]. 
The suggested mechanism of GLM-BCG ion-pair complex 
formation is shown in Scheme 3. 
Calibration curve 
The calibration curve of GLM in pure form through complexation 
with BCG showed excellent linearity over the concentration range of 
2.0-120.0 µM (0.981–58.874 μg/ml). Regression equations at λmax 
416 nm were as the follows:  
y=0.0244x+0.0011 (I) 
y=0.0245x+0.0028 (II) 
For concentrations of GLM 0.981-9.812 μg/ml and 9.812-58.874 
μg/ml, respectively, (fig. 4&5). The spectra characteristics of the 
method such as the molar absorptivity (ε), Beer's law, regression 
equation at λmax 416 nm (y=a.x+b); where y=absorbance, a=slope, 
x=concentration of GLM in μM or μg/ml,b=intercept, the correlation 
coefficient, limit of detection (LOD) and limit of quantification (LOQ) 
are summarized in table 2.  
Analytical results  
Spectrophotometric determination of GLM through complexation 
with BCG in chloroform within optimal conditions using 
calibration curve was applied. The results, summarized in table 3, 
showed that the determined concentration of GLM was rectilinear 
over the range of 2.0 to 120.0 μM or 0.981 to 58.874 μg/ml with 
relative standard deviation (RSD) not more than 3.0%. The results 
obtained from the developed method have been compared with 
the official RP-HPLC method [25] and good agreement was 
observed between them. 
 
 
Schème 3: Mechanism of GLM: BCG complex formation 
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Fig. 4: Spectra of GLM: BCG complex in present 1×10-4 M of BCG (a) and 1×10-3 M of BCG (b); where CGLM as the follows: 1-0.981, 2-1.962, 3-
2.944, 4-3.925, 5-4.906, 6-7.359, 7-9.812,  
8-14.718, 9-19.625, 10-24.530, 11-29.437, 12-39.249, 13-49.062 and 14-58.874 µg/ml, {Blank is BCG solution in chloroform: 1x10-4M (1-7) 
and 1x10-3M (7-14); ℓ = 1 cm} 
 
 
Fig. 5: Calibration curve for determination of GLM according to optimal conditions at λmax 416 nm in present of 1×10-4 M of BCG (a) and 
1×10-3 M of BCG (b); CGLM: 0.981, 1.962, 2.944, 3.925, 4.906, 7.359, 9.812 μg/ml (a) and 9.812, 14.718, 19.625, 24.530, 29.437, 39.249, 
49.062 and 58.874 μg/ml (b) {Blank is BCG solution in chloroform: 1x10-4M (a) and 1x10-3M (b); ℓ = 1 cm} 
 
Table 2: The parameters established for spectrophotometric determination of GLM by complex formation with BCG in chloroform 
Parameters Operating values 
Molar absorptivity of GLM: BCG complex (ε ), l. mol-1. cm-1 1.2x104 
Regression equation at λmax=416 nm for CGLM= 0.981-9.812 μg/ml:   
Slope 0.0244 
Intercept 0.0011 
Correlation coefficient (R2) 0.9992 
Regression equation at λmax=416 nm for CGLM= 9.812-58.874 μg/ml:   
Slope 0.0245 
Intercept 0.0028 
Correlation coefficient (R2) 0.9997 
Beer’s Law Limit, for CGLM by μM 2-120 
Beer’s Law Limit, for CGLM by µg/ml 0.981-58.874 
RSD%  3.0 
LOD(3.3SD),  for CGLM by µg/ml 0.088 




The developed method for simultaneous estimation of GLM has been 
validated in accordance with the International Conference on 
Harmonization guidelines (ICH)[26]. 
Linearity 
Several aliquots of a standard stock solution of GLM were taken in 
different 10 ml volumetric flask and diluted up to the mark with 
chloroform such that their final concentrations were 0.981-58.874 
μg/ml for GLM. Absorbance was plotted against the corresponding 
concentrations to obtain the calibration graph, see fig. 2. Linearity 
equations obtained were y = 0.0244x+0.0011 for the range 0.891-
9.812 μg/ml (R2=0.9992) and y=0.0245x+0.0028 for the range 
9.812-58.874 μg/ml (R2=0.9997).  
Precision and accuracy 
The precision and accuracy of proposed method was checked by 
recovery study by addition of standard drug solution to pre-analyzed 
sample solution at three different concentration levels (80%, 100% and 
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120%) within the range of linearity for GLM. The basic concentration 
level of sample solution selected for spiking of the GLM standard solution 
was 10μg/ml.  The proposed method was validated statistically and 
through recovery studies and was successfully applied for the 
determination of GLM in pure and dosage forms with percent recoveries 
ranged from 98.9% to 102.4%, see table 4. 
 
Table 3: Spectrophotometric determination of GLM through complex formation with BCG within optimal conditions using calibration 
curve in chloroform 




















0.98 3.0 0.98±0.036 0.013 0.029 0.98 0.981 
1.96 3.0 1.96±0.072 0.026 0.058 1.96 1.962 
2.93 2.9 2.91±0.104 0.038 0.084 2.91 2.944 
3.93 2.9 3.93±0.140 0.051 0.113 3.93 3.925 
4.90 2.8 4.87±0.169 0.061 0.136 4.87 4.906 
7.42 2.7 7.54±0.252 0.091 0.203 7.54 7.359 
9.80 2.7 9.71±0.325 0.117 0.262 9.71 9.812 
14.81 2.6 14.99±0.483 0.174 0.389 14.99 14.718 
19.54 2.5 19.48±0.605 0.218 0.487 19.48 19.625 
24.62 2.5 24.78±0.769 0.277 0.619 24.78 24.530 
29.38 2.5 29.27±0.908 0.327 0.731 29.27 29.437 
39.17 2.4 39.07±1.163 0.419 0.937 39.07 39.248 
49.41 2.4 49.68±1.480 0.533 1.192 49.68 49.062 
57.64 2.3 57.03±1.628 0.586 1.311 57.03 58.874 
* n=5, t= 2.776 
 
Table 4: Results of recovery studies 






The repeatability was evaluated by performing 10 repeat measurements 
for 9.812 μg/ml of GLM using the studied spectrophotometric method 
under the optimum conditions. The found amount of GLM ( x ± SD) was 
9.71±0.26 μg/ml and the percentage recovery was found to be 98.98±2.6 
with RSD of 0.027. These values indicate that the proposed method has 
high repeatability for GLM analysis.  
Sensitivity (limit of detection [LOD] and limit of quantitation [LOQ]) 
The sensitivity of the method was evaluated by determining the LOD 
and LOQ. The values of LOD and LOQ for GLM are 0.088 and 0.26 
μg/ml, respectively. 
Robustness 
The robustness of the method adopted is demonstrated by the 
constancy of the absorbance with the deliberated minor change in 
the experimental parameters such as the change in the 
concentration of excipients, BCG (±5%), temperature (±5 oC) and 
reaction time (30 min). 
Specificity  
The specificity of the method was ascertained by analyzing standard 
glimepiride in the presence of excipients. There was no interference 
from most of the common excipients. 
APPLICATIONS 
The developed spectrophotometric method was applied to 
determine glimepiride in some pharmaceutical preparations 
through complex formation by BCG in chloroform according to the 
optimal conditions. The amount (m) of glimepiride in one tablet was 
calculated from the following relationship: m = h. m, where: m is the 
amount of GLM in tablet calculated according to the regression 
equation (II), h conversion factor is equal to (0.1). 
 
Table 5: Determination of GLM in some Syrian pharmaceutical preparations using spectrophotometric method through complex 
formation with BCG in chloroform, λmax 416 nm 
Tablet dosage form Label Claim  





Assay * (Assay %), 
by RP-HPLC [25] 
Glimaryl 4 4.096±0.115 2.8 102.4 102.5 
2 1.970±0.060 3.0 98.5 98.7 
Amarium  4 4.020±0.113 2.8 100.5 100.3 
2 1.956±0.059 3.0 97.8 98.1 
* n=5, Assay=(found mean/label claim)x100. 
 
The results of quantitative analysis for GLM in pharmaceutical 
preparations were summarized in Tables 5. The proposed method 
was simple, direct, specific and successfully applied to the 
determination of GLM in pharmaceuticals without any interference 
from excipients. Average assay ranged between 97.8 to 102.4%. The 
results obtained by this method agree well with the contents stated 
on the labels and were validated by RP-HPLC [25]. 
CONCLUSION 
The developed spectrophotometric method is simple, direct 
(extraction-free), cost-effective and specific for the determination of 
glimepiride in pure and tablet dosage forms. This method is based on 
the formation of ion-pair complex between GLM and bromocresol 
green in chloroform (λmax 416 nm). Beer’s law in the optimum 
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experimental conditions is valid within a concentration range of 0.981-
58.874 μg/ml. The developed method is applied for the determination 
of GLM in pure and its commercial tablets without any interference 
from excipients with an average assay of marketed formulations 97.8 
to 102.4%.  
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